Effect of Scan Time on Perfusion and Flow Extraction Product (K-Trans) Measurements in Lung Cancer Using Low-Dose Volume Perfusion CT (VPCT)

Academic Radiology

Volumn 19, Issue 1, 2012, Pages 78-83

  Spira, Daniel ^a   Gerlach, Jennifer Denise ^a   Spira, Sven Michael ^b   Schulze, Maximilian ^a   Sauter, Alexander ^a   Horger, Marius ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b HEC PARIS   (France)

Author keywords

Lung cancer; Perfusion parameters; Scan time; Volume perfusion CT; VPCT

Indexed keywords

IOPROMIDE;

ADULT; ARTICLE; BLOOD FLOW; BLOOD VOLUME; CLINICAL PROTOCOL; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; FEMALE; HUMAN; LUNG CANCER; LUNG PERFUSION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION DOSE; TIME; VOLUME PERFUSION COMPUTED TOMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; BLOOD FLOW VELOCITY; BLOOD VOLUME; BLOOD VOLUME DETERMINATION; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; LUNG NEOPLASMS; MALE; MIDDLE AGED; PERFUSION IMAGING; RADIATION DOSAGE; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 82955162511     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2011.09.010     Document Type: Article

References (32)

1. Padhani A.R., Miles K.A. Multiparametric imaging of tumor response to therapy. Radiology 2010, 256:348-364.
2. Kim B.T., Lee K.S., Shim S.S., et al. Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT-a prospective study. Radiology 2006, 241:501-509.
3. Antoch G., Stattaus J., Nemat A.T., et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 2003, 229:526-533.
4. Yoo D.C., Dupuy D.E., Hillman S.L., et al. Radiofrequency ablation of medically inoperable Stage IA non-small cell lung cancer: are early posttreatment PET findings predictive of treatment outcome?. AJR Am J Roentgenol 2011, 197:334-340.
5. Petralia G., Preda L., D'Andrea G., et al. CT perfusion in solid-body tumours. Part I: technical issues. Radiol Med 2010, 115:858-874.
6. Miles K.A. Perfusion CT for the assessment of tumour vascularity: which protocol?. Br J Radiol 2003, 76(Spec No 1):S36-S42.
7. Miles K.A., Charnsangavej C., Lee F.T., et al. Application of CT in the investigation of angiogenesis in oncology. Acad Radiol 2000, 7:840-850.
8. Kambadakone A.R., Sahani D.V. Body perfusion CT: technique, clinical applications, and advances. Radiol Clin North Am 2009, 47:161-178.
9. Dawson P. Functional imaging in CT. Eur J Radiol 2006, 60:331-340.
10. Miles K.A., Griffiths M.R. Perfusion CT: a worthwhile enhancement?. Br J Radiol 2003, 76:220-231.
11. Patlak C.S., Blasberg R.G., Fenstermacher J.D. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983, 3:1-7.
12. Dawson P., Peters M. Dynamic contrast bolus computed tomography for the assessment of renal function. Invest Radiol 1993, 28:1039-1042.
13. Li Y., Yang Z.G., Chen T.W., et al. Whole tumour perfusion of peripheral lung carcinoma: evaluation with first-pass CT perfusion imaging at 64-detector row CT. Clin Radiol 2008, 63:629-635.
14. Reiner C.S., Goetti R., Eberli D., et al. CT Perfusion of renal cell carcinoma: impact of volume coverage on quantitative analysis. Invest Radiol 2011, [Epub ahead of print].
15. Goetti R., Reiner C.S., Knuth A., et al. Quantitative perfusion analysis of malignant liver tumors: dynamic computed tomography and contrast-enhanced ultrasound. Invest Radiol 2011, [Epub ahead of print].
16. Ketelsen D., Horger M., Buchgeister M., et al. Estimation of radiation exposure of 128-slice 4D-perfusion CT for the assessment of tumor vascularity. Korean J Radiol 2010, 11:547-552.
17. Saddi KA, Chefd'hofel C, Cheriet F. Large deformation registration of contrast-enhanced images with volume-preserving constraint. In: Pluim JPW, Reinhard JM, eds. Medical Imaging 2007 - Image Processing. Proceedings of the International Society for Optical Engineering (SPIE) 2007; Bellingham, WA.
18. Mineo T.C., Ambrogi V., Baldi A., et al. Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer. J Clin Pathol 2004, 57:591-597.
19. Fraioli F., Anzidei M., Zaccagna F., et al. Whole-tumor perfusion CT in patients with advanced lung adenocarcinoma treated with conventional and antiangiogenetic chemotherapy: initial experience. Radiology 2011, 259:574-582.
20. Pandharipande P.V., Krinsky G.A., Rusinek H., et al. Perfusion imaging of the liver: current challenges and future goals. Radiology 2005, 234:661-673.
21. Wang J., Chen L.T., Tsang Y.M., et al. Dynamic contrast-enhanced MRI analysis of perfusion changes in advanced hepatocellular carcinoma treated with an antiangiogenic agent: a preliminary study. AJR Am J Roentgenol 2004, 183:713-719.
22. Jiang H.J., Zhang Z.R., Shen B.Z., et al. Quantification of angiogenesis by CT perfusion imaging in liver tumor of rabbit. Hepatobiliary Pancreat Dis Int 2009, 8:168-173.
23. Lee T.Y., Purdie T.G., Stewart E. CT imaging of angiogenesis. Q J Nucl Med 2003, 47:171-187.
24. Swensen S.J., Brown L.R., Colby T.V., et al. Pulmonary nodules: CT evaluation of enhancement with iodinated contrast material. Radiology 1995, 194:393-398.
25. Zhang M., Kono M. Solitary pulmonary nodules: evaluation of blood flow patterns with dynamic CT. Radiology 1997, 205:471-478.
26. Swensen S.J., Viggiano R.W., Midthun D.E., et al. Lung nodule enhancement at CT: multicenter study. Radiology 2000, 214:73-80.
27. Li Y., Yang Z.G., Chen T.W., et al. First-pass perfusion imaging of solitary pulmonary nodules with 64-detector row CT: comparison of perfusion parameters of malignant and benign lesions. Br J Radiol 2010, 83:785-790.
28. Ma S.H., Xu K., Xiao Z.W., et al. Peripheral lung cancer: relationship between multi-slice spiral CT perfusion imaging and tumor angiogenesis and cyclin D1 expression. Clin Imaging 2007, 31:165-177.
29. Tacelli N., Remy-Jardin M., Copin M.C., et al. Assessment of non-small cell lung cancer perfusion: pathologic-CT correlation in 15 patients. Radiology 2010, 257:863-871.
30. Park M.S., Klotz E., Kim M.J., et al. Perfusion CT: noninvasive surrogate marker for stratification of pancreatic cancer response to concurrent chemo- and radiation therapy. Radiology 2009, 250:110-117.
31. Zahra M.A., Hollingsworth K.G., Sala E., et al. Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy. Lancet Oncol 2007, 8:63-74.
32. Miles K.A. Functional CT imaging in oncology. Eur Radiol 2003, 13(Suppl 5):M134-M138.